Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: June 25, 2002
Vulnerabilities abound in U.S. society. The openness and efficiency of our key infrastructures — transportation, information and telecommunications systems, health systems, the electric power grid, emergency response units, food and water supplies, and others — make them susceptible to terrorist attacks. Making the Nation Safer discusses technical approaches to mitigating these vulnerabilities.
Released: June 17, 2002
Every year approximately 30,000 people die by suicide in the United States, and one million worldwide. Over the last 100 years, suicides have out-numbered homicides by at least 3 to 2. Concerned about high suicide rates, several federal agencies joined together to ask the Institute of Medicine to convene the Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide to examine the state of the science base, gaps in our knowledge, strategies for prevention, and research designs for the study of suicide. The committee's report, Reducing Suicide: A National Imperative, explores what is known about the epidemiology, risk factors, and interventions for suicide and suicide attempts.
Released: June 12, 2002
This workshop summary report, The Role of Purchasers and Payers in the Clinical Research Enterprise, documents and summarizes what employers and insurers need from and are willing to contribute to clinical research from both a business and a national health care perspective.
Released: June 10, 2002
This report looked at the possibility that the scientific method could be accelerated to yield findings more quickly by identifying patterns of evolving evidence in nutrient-disease relationships.
Released: May 30, 2002
In the report, Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders, the Institute of Medicine (IOM) Immunization Safety Review Committee reviewed the evidence regarding the hypothesis that the hepatitis B vaccine causes demyelinating disorders.
Released: May 21, 2002
Care Without Coverage: Too Little, Too Late, the second report in a series of six from the Institiute of Medicine's Committee on the Consequences of Uninsurance, examines the real consequences for adults who lack health insurance.
Released: April 20, 2002
To explore whether soccer playing puts youths at risk for lasting brain damage, the Institute of Medicine held a workshop on October 12, 2001 at which experts in head injury, sports medicine, pediatrics, and bioengineering were asked to explore the scope of the scientific evidence regarding head injuries in youth soccer.
Released: April 16, 2002
Zoonotic diseases represent one of the leading causes of illness and death from infectious disease. Worldwide, zoonotic diseases have a negative impact on commerce, travel, and economies. In most developing countries, zoonotic diseases are among those diseases of major public health significance and contribute significantly to an already overly burdened public health system. The summary report of the workshop's presentations and discussions, The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health, includes discussion summary and individually authored papers.
Released: March 20, 2002
The report from that study, Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, found that a consistent body of research demonstrates significant variation in the rates of medical procedures by race, even when insurance status, income, age, and severity of conditions are comparable.
Released: February 20, 2002
The Immunization Safety Review committee reviewed the evidence regarding the hypothesis that multiple immunizations increase the risk for immune dysfunction, with a focus on evidence related to risk for infections, the autoimmune disease type I diabetes, and allergic disorders.